Vimarsana
Biggest News Aggregation in the World

Schizophrenia Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Schizophrenia Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Schizophrenia Study Today - Breaking & Trending Today

Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia - Vimarsana News

Antipsychotic Polypharmacy and Metabolic Disorder Risk in Individuals With Schizophrenia

What are the cardiometabolic risks of polypharmacy with quetiapine and long-acting injectable paliperidone in patients with schizophrenia?

Antipsychotic Polypharmacy and Risk of Metabolic Disorders in Schizophrenia - Vimarsana News

Antipsychotic Polypharmacy and Risk of Metabolic Disorders in Schizophrenia

What is the risk of diabetes, hypertension, or hyperlipidemia with antipsychotic polypharmacy in patients with schizophrenia? Researchers investigated these associations in a population-based prospective cohort study.